The study, involving 35,000 participants, aims to assess the vaccine’s effectiveness, and if successful, it could be included in the universal healthcare system ...

Once-daily roflumilast cream 0.05% is safe and effective for atopic dermatitis (AD) in patients ages 2 to 5 years, according ...

Patients with atopic dermatitis (AD) who achieve completely clear skin with tapinarof (Vtama) cream maintain low disease ...